These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8883229)

  • 21. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia.
    Koh A; Pizzo PA
    Cancer Invest; 2002; 20(3):420-33. PubMed ID: 12025236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
    Pater JL; Weir L
    J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New strategies in the treatment of infectious complications in haematology and oncology: is there a role for out-patient antibiotic treatment of febrile neutropenia?
    Karthaus M; Carratalà J; Jürgens H; Ganser A
    Chemotherapy; 1998; 44(6):427-35. PubMed ID: 9755304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safe and effective outpatient treatment of adults with chemotherapy-induced neutropenic fever.
    Moores KG
    Am J Health Syst Pharm; 2007 Apr; 64(7):717-22. PubMed ID: 17384356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule.
    Talcott JA; Whalen A; Clark J; Rieker PP; Finberg R
    J Clin Oncol; 1994 Jan; 12(1):107-14. PubMed ID: 8270967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Admission and care of the febrile neutropenic patient in a community hospital setting.
    Ford MS; Helsley M
    J Support Oncol; 2005; 3(6 Suppl 4):22-3. PubMed ID: 16355555
    [No Abstract]   [Full Text] [Related]  

  • 29. Current issues in the antibiotic primary management of the febrile neutropenic cancer patient: a perspective from the National Cancer Institute.
    Pizzo PA
    J Hosp Infect; 1990 Apr; 15 Suppl A():41-8. PubMed ID: 1971644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotics and growth factors in the management of fever and neutropenia in cancer patients.
    Garcia-Carbonero R; Paz-Ares L
    Curr Opin Hematol; 2002 May; 9(3):215-21. PubMed ID: 11953667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early empiric antibiotic therapy for febrile neutropenia patients at low risk.
    Rolston KV; Rubenstein EB; Freifeld A
    Infect Dis Clin North Am; 1996 Jun; 10(2):223-37. PubMed ID: 8803619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.
    Vedi A; Cohn R
    J Paediatr Child Health; 2013 Mar; 49(3):170-8. PubMed ID: 22136103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis.
    Furno P; Bucaneve G; Del Favero A
    Lancet Infect Dis; 2002 Apr; 2(4):231-42. PubMed ID: 11937423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral antibiotics for non-Hodgkin's lymphoma patients with low risk neutropenic fever--a comparative controlled study].
    Shacham-Abulafia A; Elis A; Manor Y; Lishner M
    Harefuah; 2010 Jun; 149(6):344-8, 405. PubMed ID: 20941921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of neutropenic infection: trends towards monotherapy?
    Klastersky J
    Support Care Cancer; 1997 Sep; 5(5):365-70. PubMed ID: 9322347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral moxifloxacin for outpatient treatment of low-risk, febrile neutropenic patients.
    Rolston KV; Frisbee-Hume SE; Patel S; Manzullo EF; Benjamin RS
    Support Care Cancer; 2010 Jan; 18(1):89-94. PubMed ID: 19387695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
    Petrilli A; Altruda Carlesse F; Alberto Pires Pereira C
    Pediatr Blood Cancer; 2007 Oct; 49(5):682-6. PubMed ID: 17253640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.